Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003388034 | SCV004099701 | pathogenic | Retinitis pigmentosa | 2023-09-11 | criteria provided, single submitter | clinical testing | Variant summary: EYS c.2308C>T (p.Gln770X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 153604 control chromosomes (gnomAD). c.2308C>T has been reported in the literature in at-least one individual affected with Retinitis Pigmentosa (example: Pierrache_2019). The following publication has been ascertained in the context of this evaluation (PMID: 31074760). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Baylor Genetics | RCV003463059 | SCV004195308 | pathogenic | Retinitis pigmentosa 25 | 2023-04-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003463059 | SCV005670631 | pathogenic | Retinitis pigmentosa 25 | 2024-02-13 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699706 | SCV001920250 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699706 | SCV001959058 | pathogenic | not provided | no assertion criteria provided | clinical testing |